| Dr Robert Moukarzel, MD | |
|
1014 Saint Clair Blvd, Ste 1020, Gonzales, LA 70737-5023 | |
| (225) 743-2000 | |
| (225) 743-2010 |
| Full Name | Dr Robert Moukarzel |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 38 Years |
| Location | 1014 Saint Clair Blvd, Gonzales, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285794693 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 13495R (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ochsner Home Health Of Baton Rouge | Baton rouge, LA | Home health agency |
| Ochsner Medical Center - Baton Rouge | Baton rouge, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ochsner Clinic Llc | 8224933619 | 2403 |
News Archive
An increasing understanding of molecular pathways that regulate breast and colorectal cancer development and progression has produced new therapeutic agents, including the biologic agents trastuzumab, bevacizumab, and cetuximab. Identifying the indicators that are likely to predict which patients will achieve the best response to these agents represents a major challenge for contemporary oncologists.
Inspire Pharmaceuticals, Inc. announced today that it has been communicating with the U.S. Food and Drug Administration (FDA) and is increasing its production of AzaSite® (azithromycin ophthalmic solution) 1% in response to the manufacturing supply shortage of erythromycin ophthalmic ointment (0.5%).
The move by the Democratic governor sets up an override fight with a Republican legislature that wants the ban to apply except in cases of rape, incest or if the mother's life is in danger.
TaiGen Biotechnology Company, Limited today announced that the Taiwan Food and Drug Administration has approved the new drug application (NDA) of Taigexyn (nemonoxacin) oral formulation (500 mg) for the treatment of community-acquired bacterial pneumonia (CAP). With this NDA approval, Taiwan is the first region to grant marketing approval to Taigexyn.
› Verified 8 days ago
| Entity Name | Ochsner Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538151428 PECOS PAC ID: 8224933619 Enrollment ID: O20031126000513 |
News Archive
An increasing understanding of molecular pathways that regulate breast and colorectal cancer development and progression has produced new therapeutic agents, including the biologic agents trastuzumab, bevacizumab, and cetuximab. Identifying the indicators that are likely to predict which patients will achieve the best response to these agents represents a major challenge for contemporary oncologists.
Inspire Pharmaceuticals, Inc. announced today that it has been communicating with the U.S. Food and Drug Administration (FDA) and is increasing its production of AzaSite® (azithromycin ophthalmic solution) 1% in response to the manufacturing supply shortage of erythromycin ophthalmic ointment (0.5%).
The move by the Democratic governor sets up an override fight with a Republican legislature that wants the ban to apply except in cases of rape, incest or if the mother's life is in danger.
TaiGen Biotechnology Company, Limited today announced that the Taiwan Food and Drug Administration has approved the new drug application (NDA) of Taigexyn (nemonoxacin) oral formulation (500 mg) for the treatment of community-acquired bacterial pneumonia (CAP). With this NDA approval, Taiwan is the first region to grant marketing approval to Taigexyn.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Moukarzel, MD 1014 Saint Clair Blvd, Ste 1020, Gonzales, LA 70737-5023 Ph: (225) 743-2000 | Dr Robert Moukarzel, MD 1014 Saint Clair Blvd, Ste 1020, Gonzales, LA 70737-5023 Ph: (225) 743-2000 |
News Archive
An increasing understanding of molecular pathways that regulate breast and colorectal cancer development and progression has produced new therapeutic agents, including the biologic agents trastuzumab, bevacizumab, and cetuximab. Identifying the indicators that are likely to predict which patients will achieve the best response to these agents represents a major challenge for contemporary oncologists.
Inspire Pharmaceuticals, Inc. announced today that it has been communicating with the U.S. Food and Drug Administration (FDA) and is increasing its production of AzaSite® (azithromycin ophthalmic solution) 1% in response to the manufacturing supply shortage of erythromycin ophthalmic ointment (0.5%).
The move by the Democratic governor sets up an override fight with a Republican legislature that wants the ban to apply except in cases of rape, incest or if the mother's life is in danger.
TaiGen Biotechnology Company, Limited today announced that the Taiwan Food and Drug Administration has approved the new drug application (NDA) of Taigexyn (nemonoxacin) oral formulation (500 mg) for the treatment of community-acquired bacterial pneumonia (CAP). With this NDA approval, Taiwan is the first region to grant marketing approval to Taigexyn.
› Verified 8 days ago
Matthew Duane Copple, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1014 Saint Clair Blvd Ste 1020, Gonzales, LA 70737 Phone: 225-743-2000 Fax: 225-743-2010 | |
Mr. Chad Loup, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1023 W Highway 30, Gonzales, LA 70737 Phone: 225-743-2366 Fax: 225-743-2369 | |
Matthew S Fury, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1014 Saint Clair Blvd Ste 1000, Gonzales, LA 70737 Phone: 225-215-4417 Fax: 225-390-1414 | |
Dr. Scott George Petrie, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1014 W Saint Clare Blvd, Suite 1020, Gonzales, LA 70737 Phone: 225-743-2000 Fax: 225-743-2010 |